J. M. González de Aledo-Castillo

An incidental finding in newborn screening leading to the diagnosis of a patient with ECHS1 mutations

J. A. Arranz, F. Tort, A. Ribes, 2020, Molecular genetics and metabolism reports.

Molecular characterization of advanced non-small cell lung cancer patients by cfDNA analysis: experience from routine laboratory practice

P. Jares, N. Viñolas, N. Reguart, 2021, Journal of thoracic disease.

First Universal Newborn Screening Program for Severe Combined Immunodeficiency in Europe. Two-Years' Experience in Catalonia (Spain)

P. Soler-Palacín, A. Ribes, R. Colobran, 2019, Front. Immunol..

Newborn Screening for SCID. Experience in Spain (Catalonia)

P. Soler-Palacín, A. Ribes, R. Colobran, 2021, International journal of neonatal screening.

Technical Evaluation of the COBAS EGFR Semiquantitative Index (SQI) for Plasma cfDNA Testing in NSCLC Patients with EGFR Exon 19 Deletions

P. Jares, N. Reguart, J. Puig-Butillé, 2021, Diagnostics.

Genome‐wide postnatal changes in immunity following fetal inflammatory response

R. Castelo, E. Sabidó, Núria Bonet, 2019, The FEBS journal.